Hochschulschrift
Modulation of glycine receptor function by the synthetic cannabinoid HU210
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Anmerkungen
-
Hannover, Med. Hochsch., Diss., 2011
- Schlagwort
-
Biopharmazie
Pharmakodynamik
Pharmakokinetik
- Ereignis
-
Veröffentlichung
- (wo)
-
Hannover
- (wer)
-
Bibliothek der Medizinischen Hochschule Hannover
- (wann)
-
2011
- Urheber
- Beteiligte Personen und Organisationen
- URN
-
urn:nbn:de:gbv:354-20110617225
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Demir, Reyhan
- Ahrens, Jörg
- Bibliothek der Medizinischen Hochschule Hannover
Entstanden
- 2011
Ähnliche Objekte (12)
Activity-based detection of synthetic cannabinoid receptor agonists in plant materials
Conformational transitions and allosteric modulation in a heteromeric glycine receptor
A millisecond coarse-grained simulation approach to decipher allosteric cannabinoid binding at the glycine receptor α1
Characterization of the synthetic cannabinoid MDMB-CHMCZCA
The role of the cannabinoid receptor 2 in the modulation of neuropathic pain
The role of the cannabinoid receptor 2 in the modulation of neuropathic pain
Post-mortem toxicology: a systematic review of death cases involving synthetic cannabinoid receptor agonists
Cumyl‐CBMICA: a new synthetic cannabinoid receptor agonist containing a cyclobutyl methyl side chain
GPR55 is a novel cannabinoid receptor
Pharmacology, prevalence in Germany, and analytical data of cyclobutylmethyl‐ and norbornylmethyl‐type synthetic cannabinoid receptor agonists
The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients
Structural basis for cannabinoid-induced potentiation of alpha1-glycine receptors in lipid nanodiscs
Activity-based detection of synthetic cannabinoid receptor agonists in plant materials
Conformational transitions and allosteric modulation in a heteromeric glycine receptor
A millisecond coarse-grained simulation approach to decipher allosteric cannabinoid binding at the glycine receptor α1
Characterization of the synthetic cannabinoid MDMB-CHMCZCA
The role of the cannabinoid receptor 2 in the modulation of neuropathic pain
The role of the cannabinoid receptor 2 in the modulation of neuropathic pain
Post-mortem toxicology: a systematic review of death cases involving synthetic cannabinoid receptor agonists
Cumyl‐CBMICA: a new synthetic cannabinoid receptor agonist containing a cyclobutyl methyl side chain
GPR55 is a novel cannabinoid receptor
Pharmacology, prevalence in Germany, and analytical data of cyclobutylmethyl‐ and norbornylmethyl‐type synthetic cannabinoid receptor agonists
The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients
Structural basis for cannabinoid-induced potentiation of alpha1-glycine receptors in lipid nanodiscs
Activity-based detection of synthetic cannabinoid receptor agonists in plant materials
Conformational transitions and allosteric modulation in a heteromeric glycine receptor
A millisecond coarse-grained simulation approach to decipher allosteric cannabinoid binding at the glycine receptor α1
Characterization of the synthetic cannabinoid MDMB-CHMCZCA
The role of the cannabinoid receptor 2 in the modulation of neuropathic pain
The role of the cannabinoid receptor 2 in the modulation of neuropathic pain
Post-mortem toxicology: a systematic review of death cases involving synthetic cannabinoid receptor agonists
Cumyl‐CBMICA: a new synthetic cannabinoid receptor agonist containing a cyclobutyl methyl side chain
GPR55 is a novel cannabinoid receptor
Pharmacology, prevalence in Germany, and analytical data of cyclobutylmethyl‐ and norbornylmethyl‐type synthetic cannabinoid receptor agonists
The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients